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Background
Prolonged treatment with tenofovir (TDF) containing
HAART is associated with reductions in kidney tubular
resorption of phosphorus (P). Added to this, TDF may
directly affect bone remodeling. Current study analyses
the potential repercussion of Calcium (Ca) and P wast-
ing on bone-mineral metabolism.
Methods
All consecutive asymptomatic HIV-infected patients
starting first-line HAART were recruited. Patients
receiving HARRT with vs without TDF were considered
separately. Changes with respect to baseline values in
Ca and P plasma levels, alkaline phosphatase (AP) con-
centration and parathyroid hormone (PTH) levels were
analyzed in patients followed for longer than 12 months.
Adherence >95% as assessed every 4 months was
requested to remain in the study.
Results
A total of101 patients were included, 64 (63%) received
TDF and 37 (37%) non-TDF containing HAART (mean
age 38 years-old, 92% males, 90% Caucasians, mean CD4
count 278 cells/uL, mean HIV-RNA 4.3 log copies/mL,
without differences between groups). After a mean follow
up of 18 months, mean variation in bone-mineral meta-
bolism plasma parameters with respect to baseline values,
in patients under TDF vs non-TDF, was respectively as
follows: P levels -0.31 mgr/dL [p < 0.001] vs -0.05 mg/dL
[p = 0.7]; Ca levels +0.24 mg/dL [p = 0.005] vs +0.23 mg/
dL [p = 0.36]; AP concentration +60 IU/L [p = 0.005] vs
-36 IU/L [p = 0.09]; and PTH levels +20.3 pgr/mL
[p = 0.02] vs +12.6 pgr/mL [p = 0.25].
Discussion
First-line HAART containing TDF, as compared with
other nucleoside analogs, is associated with significant
reductions in P levels, and increase in AP and PTH con-
centrations. These alterations are recognized markers of
enhanced bone resorption, and may herald osteopenia
in the long-term.
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